Oncology

Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...

24 Feb 2015  |  Asia Pacific

Analysis of the Global Oncology Drug Delivery Market

Future Impact of Emerging Technologies

Infographics

×

The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...

Oncology diagnosis and biomarker technology is a multidisciplinary field within healthcare technologies. Imaging forms an essential part of cancer clinical protocols and is able to furnish morphological, structural, metabolic and functional information. Biomedical imaging is one of the main pillars of oncology imaging and cancer care. Modern medica...

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In Oncology, developers are interested in understanding the opportunities and parameters for delivery of drugs in outpatient settings, particularly the home. This is important for biotechnology products used in this area as companies seek to des...

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimburs...

Overview of Indian oncology market presents an all-encompassing research of Oncology markets for various cancers: Breast cancer, Lung Cancer, Ovarian cancer, Prostate cancer, Head and Neck cancer, Cervical cancer, Renal cell carcinoma and Pancreatic cancer. The research focuses on pharmaceutical industry spending in various segments of cancer treat...